M.D.C. Stock Price, Forecast & Analysis (NYSE:MDC)

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C. announced a quarterly dividend on Monday, October 28th. Shareholders of record on Wednesday, November 13th will be paid a dividend of $0.30 per share on Wednesday, November 27th. This represents a $1.20 dividend on an annualized basis and a yield of 3.14%. The ex-dividend date of this dividend is Tuesday, November 12th. View M.D.C.'s Dividend History.

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings results on Wednesday, October, 30th. The construction company reported $0.79 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by $0.08. The construction company had revenue of $750.27 million for the quarter, compared to analysts' expectations of $767.23 million. M.D.C. had a net margin of 6.58% and a return on equity of 12.73%. The firm's revenue was down 2.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.86 earnings per share. View M.D.C.'s Earnings History.

M.D.C. is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for M.D.C..

5 brokers have issued 12-month price targets for M.D.C.'s stock. Their forecasts range from $41.00 to $49.00. On average, they anticipate M.D.C.'s share price to reach $45.00 in the next year. This suggests a possible upside of 17.8% from the stock's current price. View Analyst Price Targets for M.D.C..

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 3 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for M.D.C..

Press coverage about MDC stock has trended positive recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. M.D.C. earned a news impact score of 2.2 on InfoTrie's scale. They also assigned media coverage about the construction company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for M.D.C..

M.D.C. saw a increase in short interest in the month of October. As of October 15th, there was short interest totalling 2,080,000 shares, an increase of 6.7% from the September 15th total of 1,950,000 shares. Based on an average trading volume of 479,700 shares, the short-interest ratio is presently 4.3 days. Approximately 4.2% of the company's shares are short sold. View M.D.C.'s Current Options Chain.

Some companies that are related to M.D.C. include D. R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), KB Home (KBH), Meritage Homes (MTH), TRI Pointe Group (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH), Hovnanian Enterprises (HOV) and Ryland Group (RYL).

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Bank of Hawaii (BOH), InterDigital Wireless (IDCC), Stag Industrial (STAG), Procter & Gamble (PG), Celgene (CELG), Intel (INTC), Ford Motor (F), Cisco Systems (CSCO), Gilead Sciences (GILD) and Micron Technology (MU).

M.D.C.'s stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Hamlin Capital Management LLC (2.76%), Strs Ohio (0.53%), Smith Graham & Co. Investment Advisors LP (0.50%), Fisher Asset Management LLC (0.29%), Rhumbline Advisers (0.28%) and Lesa Sroufe & Co (0.21%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Institutional Ownership Trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, Hamlin Capital Management LLC, First Trust Advisors LP, WBI Investments Inc., Mackay Shields LLC, Lesa Sroufe & Co, Alberta Investment Management Corp and Municipal Employees Retirement System of Michigan. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View Insider Buying and Selling for M.D.C..

MDC stock was purchased by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Bowling Portfolio Management LLC, Acorn Advisory Capital L.P., Price Capital Management Inc., Chicago Equity Partners LLC, Denali Advisors LLC, State of Alaska Department of Revenue and BBVA USA Bancshares Inc.. View Insider Buying and Selling for M.D.C..

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDC stock can currently be purchased for approximately $38.21.

M.D.C. has a market capitalization of $2.37 billion and generates $2.98 billion in revenue each year. The construction company earns $210.78 million in net income (profit) each year or $3.67 on an earnings per share basis. M.D.C. employs 1,581 workers across the globe.View Additional Information About M.D.C..

The official website for M.D.C. is http://www.mdcholdings.com/.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]